Agilent Technologies, Inc.
Agilent Technologies, Inc. is a healthcare company headquartered in Santa Clara, USA. Listed on the NYSE since its IPO in 1999, the company delivers specialized technologies and services to the global life sciences, diagnostics, and applied chemistry industries. The business operates through three primary segments.…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
1D
-1.5%
1W
+1.4%
1M
+12.5%
6M
+41.9%
YTD
+27.1%
1Y
+22.6%
2Y
+24.3%
5Y
+12.9%
10Y
+283.7%
Next earnings date
23/11/2026 (in 37 days)
Volatility around earnings
~31% stronger price swings than usual
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Visible after free registration
Register for free
Unlock all 11 scores
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.
2 more assignments (Enabler/Second row) Pro-only.
Agilent Technologies is a provider of specialized technologies and services for the life sciences, diagnostics, and applied chemistry industries. The business model encompasses the sale of complex analytical instruments such as chromatography and mass spectrometry systems, as well as software solutions for data analysis and genomics research. Beyond hardware sales, the company generates substantial revenues through consumables, reagents, services (Agilent CrossLab), and software-as-a-service offerings. By combining highly specialized instrumentation with the associated necessary consumables and software-enabled workflows, the company establishes strong customer loyalty across various global markets.
PRICE TARGET LOW
US$150.00
CONSENSUS
US$173.08
MEDIAN
US$175.00
PRICE TARGET HIGH
US$195.00
1
STRONG BUY
32
BUY
7
HOLD
1
SELL
0
STRONG SELL
41
TOTAL · Buy
As of: 13/10/2026
P/E
33.98
P/B
6.62
EV/EBITDA
25.04
RETURN ON EQUITY
4.9%
NET MARGIN
19.3%
DEBT/EQUITY
0.54
DIVIDEND YIELD
0.6%
AS OF
31/07/2026
FREE FLOAT
99.6%
FLOAT SHARES
280,978,899
AVG. DAILY VOLUME (30D)
2,337,048
Boehnlein Glenn S
Dolsten Mikael
KIRKWOOD JONAH PREVOST
MCDONNELL PADRAIG
Dolsten Mikael
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -1.5%
Forums (Reddit)
Agilent Technologies, Inc. is a company in the Healthcare sector, Medical - Diagnostics & Research industry, headquartered in United States.
The CEO is Padraig McDonnell, the company employs around 18,200 people.
The IPO was on 18/11/1999; the stock trades on NYSE under the ticker A.
41 analysts rate the stock, the consensus is Buy (as of 13/10/2026).
The average price target is US$173.08, ranging from US$150.00 to US$195.00, with a median of US$175.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 23/11/2026.
Around past earnings, price swings were roughly 31% stronger than usual.
Yes. The last dividend was US$0.26 per share, ex-date 06/10/2026, paid on 28/10/2026.
The dividend yield is 0.6% (as of 31/07/2026).
Comparable stocks include Thermo Fisher Scientific, Danaher, Natera, IQVIA Holdings, Waters, Illumina, IDEXX Laboratories and Mettler-Toledo International.
Clicking "Analyze stock" lets five strategies assess Agilent Technologies against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.